Exploring MEM. To explore a different substance…

PiHKAL#122 MEM; SI#87 MEM
Names:
MEM · 2,5-Dimethoxy-4-ethoxyamphetamine
IUPAC name:
1-(4-Ethoxy-2,5-dimethoxyphenyl)propan-2-amine
ID: 122 · Formula: C13H21NO3 · Molecular weight: 239.311
InChI: InChI=1S/C13H21NO3/c1-5-17-13-8-11(15-3)10(6-9(2)14)7-12(13)16-4/h7-9H,5-6,14H2,1-4H3

Trachsel, D. Fluorine in psychedelic phenethylamines. Drug Test. Analysis, 13 Dec 2011. 1038 kB. http://dx.doi.org/10.1002/dta.413

Shulgin, AT. Chemistry and structure-activity relationships of the psychotomimetics. In Psychotomimetic Drugs; Efron, DH, Ed., Raven Press, New York, 1 Jan 1970; pp 21–41. 8647 kB.

Foster, BC; McLeish, J; Wilson, DL; Whitehouse, LW; Zamecnik, J; Lodge, BA. Biotransformation of tri-substituted methoxyamphetamines by Cunninghamella echinulata. Xenobiotica, 1992, 22 (12), 1383–1394. 765 kB. http://dx.doi.org/10.3109/00498259209056689

By, AW; Dawson, BA; Lodge, BA; Neville, GA; Sy, W; Zamecnik, J. Synthesis and spectral properties of 2,5-dimethoxy-4-ethoxyamphetamine and its precursors. J. Forensic Sci., 1 Mar 1990, 35 (2), 316–335. 538 kB. http://dx.doi.org/10.1520/JFS12833J

Ray, TS. Psychedelics and the human receptorome. PLOS ONE, 2 Feb 2010, 5 (2), e9019. 791 kB. http://dx.doi.org/10.1371/journal.pone.0009019

Shulgin, AT; Sargent, T; Naranjo, C. Structure-activity relationships of one-ring psychotomimetics. Nature, 1 Jan 1969, 221, 537–541. 537 kB. http://dx.doi.org/10.1038/221537a0

Shulgin, AT. The ethyl homologs of 2,4,5-trimethoxyphenylisopropylamine. J. Med. Chem., 1 Jan 1968, 11 (1), 186–187. 242 kB. http://dx.doi.org/10.1021/jm00307a056

Seggel, MR; Yousif, MY; Lyon, RA; Titeler, M; Roth, BL; Suba, EA; Glennon, RA. A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors. J. Med. Chem., 1 Mar 1990, 33 (3), 1032–1036. 807 kB. http://dx.doi.org/10.1021/jm00165a023

Glennon, RA; Raghupathi, R; Bartyzel, P; Teitler, M; Leonhardt, S. Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity. J. Med. Chem., 1 Feb 1992, 35 (4), 734–740. 1054 kB. http://dx.doi.org/10.1021/jm00082a014

Glennon, RA; Seggel, MR. Interaction of phenylisopropylamines with central 5-HT2 receptors. Analysis by quantitative structure-activity relationships. In Probing Bioactive Mechanisms; ACS Symposium Series; Magee, PS; Henry, DR; Block, JH, Eds., American Chemical Society, Washington, DC, 14 Nov 1989; Vol. 413, pp 264–280. 4445 kB. http://dx.doi.org/10.1021/bk-1989-0413.ch018

Halberstadt, AL; Geyer, MA. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology, 1 Sep 2011, 61 (3) 364–381. 817 kB. http://dx.doi.org/10.1016/j.neuropharm.2011.01.017

Thakur, M; Thakur, A; Khadikar, PV. QSAR studies on psychotomimetic phenylalkylamines. Bioorg. Med. Chem., 15 Feb 2004, 12 (4), 825–831. 323 kB. http://dx.doi.org/10.1016/j.bmc.2003.10.027

Altun, A; Golcuk, K; Kumru, M; Jalbout, AF. Electron-conformation study for the structure-hallucinogenic activity relationships of phenylalkylamines. Bioorg. Med. Chem., 1 Dec 2003, 11 (24), 3861–3868. 577 kB. http://dx.doi.org/10.1016/S0968-0896(03)00437-1

Glennon, RA; Dukat, M; Grella, B; Hong, S; Costantino, L; Teitler, M; Smith, C; Egan, C; Davis, K; Mattson, MV. Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors. Drug Alcohol Depend., 1 Aug 2000, 60 (2), 121–132. 276 kB. http://dx.doi.org/10.1016/S0376-8716(99)00148-9

Corrigall, WA; Coen, KM; Saouda, FM; Robertson, JM; Lodge, BA. Discriminative stimulus properties of substituted amphetamine derivatives. Pharmacol. Biochem. Behav., 1 Dec 1992, 43 (4), 1117–1119. 265 kB. http://dx.doi.org/10.1016/0091-3057(92)90490-7

Glennon, RA; Rosecrans, JA; Young, R. Behavioral properties of psychoactive phenylisopropylamines in rats. Eur. J. Pharmacol., 17 Dec 1981, 76 (4), 353–360. 964 kB. http://dx.doi.org/10.1016/0014-2999(81)90106-0

Shulgin, AT. Psychotomimetic drugs: structure-activity relationships. In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1 Jan 1978; Vol. 11, pp 243–333. 2584 kB. http://dx.doi.org/10.1007/978-1-4757-0510-2_6 Rhodium.

N-Acetyl MEM
N-Acetyl MEM; N-[1-(4-Ethoxy-2,5-dimethoxyphenyl)propan-2-yl]acetamide
2C-O-2
2C-O-2; 2,5-Dimethoxy-4-ethoxyphenethylamine
4C-EtO
4C-EtO; 1-(4-Ethoxy-2,5-dimethoxyphenyl)-2-aminobutane
EEM
PiHKAL#74 EEM
ALEPH
PiHKAL#3 ALEPH; SI#3 ALEPH
ALEPH-2
PiHKAL#4 ALEPH-2; SI#4 ALEPH-2
ALEPH-4
PiHKAL#5 ALEPH-4; SI#5 ALEPH-4
ALEPH-6
PiHKAL#6 ALEPH-6
ALEPH-7
PiHKAL#7 ALEPH-7; SI#6 ALEPH-7
2,5-DMA
PiHKAL#54 2,5-DMA; SI#36 2,5-DMA
DOAM
PiHKAL#61 DOAM; SI#51 DOAM
DOB
PiHKAL#62 DOB; SI#52 DOB
DOBU
PiHKAL#63 DOBU; SI#53 DOBU
DOC
PiHKAL#64 DOC; SI#54 DOC
DOEF
PiHKAL#65 DOEF
DOET
PiHKAL#66 DOET; SI#56 DOET
DOI
PiHKAL#67 DOI; SI#58 DOI
DOM
PiHKAL#68 DOM; SI#60 DOM
DON
PiHKAL#70 DON; SI#61 DON
DOPR
PiHKAL#71 DOPR; SI#62 DOPR
MPM
PiHKAL#138 MPM
TMA-2
PiHKAL#158 TMA-2; SI#118 TMA-2
DOF
DOF; 2,5-Dimethoxy-4-fluoro-amphetamine
DOIB
DOIB; 2,5-Dimethoxy-4-(2-methylpropyl)amphetamine
DOTB
DOTB; 2,5-Dimethoxy-4-(1,1-dimethylethyl)amphetamine
DOSB
DOSB; 2,5-Dimethoxy-4-(1-methylpropyl)amphetamine
DONH · DOA
DONH; 2,5-Dimethoxy-4-aminoamphetamine
DOAA
DOAA; 2,5-Dimethoxy-4-acetamidoamphetamine
Hydroxy-DOPR
Hydroxy-DOPR; 2,5-Dimethoxy-4-(1-hydroxypropyl)amphetamine
DOIP
DOIP; 2,5-Dimethoxy-4-isopropylamphetamine
MIPM
MIPM; 2,5-Dimethoxy-4-isopropoxyamphetamine
MBM
MBM; 4-n-Butoxy-2,5-dimethoxyamphetamine
MAM
MAM; 4-n-Amyloxy-2,5-dimethoxyamphetamine
DOHE
DOHE; 4-Hexyl-2,5-dimethoxyamphetamine
DOBZ
DOBZ; 4-Benzyl-2,5-dimethoxyamphetamine
DOCPM
DOCPM; 4-Cyclopropylmethyl-2,5-dimethoxyamphetamine
ALEPH-8
ALEPH-8; 4-Cyclopropylmethylthio-2,5-dimethoxyamphetamine
ALEPH-5
ALEPH-5; 4-Cyclohexylthio-2,5-dimethoxyamphetamine
ALEPH-16
ALEPH-16; 4-Allylthio-2,5-dimethoxyamphetamine
ALEPH-21
ALEPH-21; 4-(2-Fluoroethylthio)-2,5-dimethoxyamphetamine
DOTFM
DOTFM; 2,5-Dimethoxy-4-(trifluoromethyl)amphetamine
2328
2,5-Dimethoxy-4-phenylbutylamphetamine
DOYN
DOYN; 4-Ethynyl-2,5-dimethoxyamphetamine
DOCN
DOCN; 4-Cyano-2,5-dimethoxyamphetamine
DOPh3
DOPh3; 2,5-Dimethoxy-4-phenylpropylamphetamine
2325
2,5-Dimethoxy-4-phenethylamphetamine
2329
4-(4-Chlorophenylpropyl)-2,5-dimethoxyamphetamine
2330
2,5-Dimethoxy-4-(4-methoxyphenylpropyl)amphetamine
DOVI
DOVI; 1-(4-Ethenyl-2,5-dimethoxyphenyl)propan-2-amine
DOAC
DOAC; 4-Acetyl-2,5-dimethoxyamphetamine
DOCA
DOCA; 4-Carboxy-2,5-dimethoxyamphetamine
DOOH
DOOH; 4-Hydroxy-2,5-dimethoxyamphetamine
DOCONHP
DOCONHP; 2,5-Dimethoxy-4-(propylaminocarbonyl)amphetamine
DOCOE
DOCOE; 2,5-Dimethoxy-4-propanonylamphetamine
DOCEB
DOCEB; 4-Butoxycarbonyl-2,5-dimethoxyamphetamine
DOCEP
DOCEP; 2,5-Dimethoxy-4-propoxycarbonylamphetamine
DOOC
DOOC; 2,5-Dimethoxy-4-n-octylamphetamine
DONMM
DONMM; 4-(2-Aminopropyl)-2,5-dimethoxy-N,N-dimethylaniline
DOFM
DOFM; 1-[4-(Fluoromethyl)-2,5-dimethoxyphenyl]propan-2-amine
DOHM
DOHM; 4-(2-Aminopropyl)-2,5-dimethoxybenzaldehyde
DOHP
DOHP; 1-(4-Heptyl-2,5-dimethoxyphenyl)propan-2-amine
DONO
DONO; 1-(2,5-Dimethoxy-4-nonylphenyl)propan-2-amine
DOEH
DOEH; 2-[4-(2-Aminopropyl)-2,5-dimethoxyphenyl]ethanol
M(2OP)M
M(2OP)M; 1-[4-(2-Aminopropyl)-2,5-dimethoxyphenoxy]propan-2-ol
M(3OP)M
M(3OP)M; 3-[4-(2-Aminopropyl)-2,5-dimethoxyphenoxy]propan-1-ol
MBZM
MBZM; 1-[4-(Benzyloxy)-2,5-dimethoxyphenyl]propan-2-amine
ALEPH-19
ALEPH-19; 1-[4-(Butylsulfanyl)-2,5-dimethoxyphenyl]propan-2-amine
ALEPH-S-amyl
ALEPH-S-amyl; 1-[2,5-Dimethoxy-4-(pentylsulfanyl)phenyl]propan-2-amine
ALEPH-S-PhEt
ALEPH-S-PhEt; 1-{2,5-Dimethoxy-4-[(2-phenylethyl)sulfanyl]phenyl}propan-2-amine
ALEPH sulfone
ALEPH sulfone; 1-[2,5-Dimethoxy-4-(methylsulfonyl)phenyl]propan-2-amine
DOTFE
DOTFE; 1-[2,5-Dimethoxy-4-(2,2,2-trifluoroethyl)phenyl]propan-2-amine
MTFEM
MTFEM; 1-[2,5-Dimethoxy-4-(2,2,2-trifluoroethoxy)phenyl]propan-2-amine
MDFEM
MDFEM; 1-[4-(2,2-Difluoroethoxy)-2,5-dimethoxyphenyl]propan-2-amine
MFEM
MFEM; 1-[4-(2-Fluoroethoxy)-2,5-dimethoxyphenyl]propan-2-amine
DOBM
DOBM; 1-[4-(Bromomethyl)-2,5-dimethoxyphenyl]propan-2-amine
DOMCl
DOMCl; 1-[4-(Chloromethyl)-2,5-dimethoxyphenyl]propan-2-amine
DOCET
DOCET; 1-[4-(2-Chloroethyl)-2,5-dimethoxyphenyl]propan-2-amine
DOTFPR
DOTFPR; 1-[2,5-Dimethoxy-4-(3,3,3-trifluoropropyl)phenyl]propan-2-amine
DOHSM
DOHSM; [4-(2-Aminopropyl)-2,5-dimethoxyphenyl]methanethiol
DOMSM
DOMSM; 1-{2,5-Dimethoxy-4-[(methylsulfanyl)methyl]phenyl}propan-2-amine
DOMOM
DOMOM; 1-[2,5-Dimethoxy-4-(methoxymethyl)phenyl]propan-2-amine
DONCO
DONCO; N-[4-(2-Aminopropyl)-2,5-dimethoxyphenyl]formamide
DONCOE
DONCOE; N-[4-(2-Aminopropyl)-2,5-dimethoxyphenyl]propanamide
DONCOTFM
DONCOTFM; N-[4-(2-Aminopropyl)-2,5-dimethoxyphenyl]-2,2,2-trifluoroacetamide
DOCNM
DOCNM; [4-(2-Aminopropyl)-2,5-dimethoxyphenyl]acetonitrile
1016
[4-(2-Aminopropyl)-2,5-dimethoxyphenyl]methanol
MEE
PiHKAL#121 MEE
AEM
PiHKAL#1 AEM; SI#1 AEM
ASB
PiHKAL#9 ASB; SI#8 ASB
3C-E
PiHKAL#25 3C-E
2C-O-4
PiHKAL#35 2C-O-4
EMM
PiHKAL#76 EMM
IP
PiHKAL#92 IP
MME
PiHKAL#136 MME
MP
PiHKAL#137 MP
P
PiHKAL#140 P; SI#104 Proscaline
SB
PiHKAL#144 SB
189
1-(2,5-Dimethoxy-4-methylphenyl)-N-hydroxy-2-aminobutane
4C-TMPEA-6
4C-TMPEA-6; 1-(2,4,6-Trimethoxyphenyl)-2-aminobutane
BOED
BOED; 2,5-Dimethoxy-β-ethoxy-4-methylphenethylamine
Z-7.2
Z-7.2; 4-Methyl-2,3,6-trimethoxyamphetamine
Trichocerine
Trichocerine
N-Me-TMA · METHYL-TMA
N-Me-TMA; N-Methyl-3,4,5-trimethoxyamphetamine
N-Me-TMA-2 · METHYL-TMA-2
N-Me-TMA-2; N-Methyl-2,4,5-trimethoxyamphetamine
N-Me-TMA-6 · METHYL-TMA-6
N-Me-TMA-6; N-Methyl-2,4,6-trimethoxyamphetamine
2C-O-7
2C-O-7; 2,5-Dimethoxy-4-n-propoxyphenethylamine
Salbutamol
Salbutamol
homo-TMA-2
homo-TMA-2; 4-(2,4,5-Trimethoxyphenyl)butan-2-amine
homo-TMA-3
homo-TMA-3; 4-(2,3,4-Trimethoxyphenyl)butan-2-amine
homo-TMA-6
homo-TMA-6; 4-(2,4,6-Trimethoxyphenyl)butan-2-amine
N,N-Me-β,3,4-TMPEA
N,N-Me-β,3,4-TMPEA; 2-(3,4-Dimethoxyphenyl)-2-methoxy-N,N-dimethylethan-1-amine
β-HO-β,N,N-Me-2,5-DMPEA
β-HO-β,N,N-Me-2,5-DMPEA; 2-(2,5-Dimethoxyphenyl)-1-(dimethylamino)propan-2-ol
β-HO-N,N-Me-2,5-DMA
β-HO-N,N-Me-2,5-DMA; 1-(2,5-Dimethoxyphenyl)-2-(dimethylamino)propan-1-ol
β-HO-N-Me-2,5-DEPEA
β-HO-N-Me-2,5-DEPEA; 1-(2,5-Diethoxyphenyl)-2-(methylamino)ethanol
β-HO-2,5-DEA
β-HO-2,5-DEA; 2-Amino-1-(2,5-diethoxyphenyl)propan-1-ol
N-Me-TMA-3
N-Me-TMA-3; N-Methyl-1-(2,3,4-trimethoxyphenyl)propan-2-amine
4C-TMPEA-3
4C-TMPEA-3; 1-(2,3,4-Trimethoxyphenyl)butan-2-amine
4C-HM
4C-HM; 4-(2-Aminobutyl)-2,5-dimethoxybenzaldehyde
BOE
BOE; 2-(4-Ethyl-2,5-dimethoxyphenyl)-2-methoxyethan-1-amine
DOEH
DOEH; 2-[4-(2-Aminopropyl)-2,5-dimethoxyphenyl]ethanol
4C-MeO
4C-MeO; 1-(2,4,5-Trimethoxyphenyl)butan-2-amine
DESMETHYL-iPr
DESMETHYL-iPr; 2,6-Dimethoxy-4-[2-(propan-2-ylamino)ethyl]phenol
α-MM-M
α-MM-M; 2-Methyl-1-(3,4,5-trimethoxyphenyl)propan-2-amine
DOMOM
DOMOM; 1-[2,5-Dimethoxy-4-(methoxymethyl)phenyl]propan-2-amine
N-Acetyl MEM
N-Acetyl MEM; N-[1-(4-Ethoxy-2,5-dimethoxyphenyl)propan-2-yl]acetamide
2C-O-2
2C-O-2; 2,5-Dimethoxy-4-ethoxyphenethylamine
4C-EtO
4C-EtO; 1-(4-Ethoxy-2,5-dimethoxyphenyl)-2-aminobutane
EEM
PiHKAL#74 EEM
ALEPH
PiHKAL#3 ALEPH; SI#3 ALEPH
ALEPH-2
PiHKAL#4 ALEPH-2; SI#4 ALEPH-2
ALEPH-4
PiHKAL#5 ALEPH-4; SI#5 ALEPH-4
ALEPH-6
PiHKAL#6 ALEPH-6
ALEPH-7
PiHKAL#7 ALEPH-7; SI#6 ALEPH-7
2,5-DMA
PiHKAL#54 2,5-DMA; SI#36 2,5-DMA
DOAM
PiHKAL#61 DOAM; SI#51 DOAM
DOB
PiHKAL#62 DOB; SI#52 DOB
DOBU
PiHKAL#63 DOBU; SI#53 DOBU
DOC
PiHKAL#64 DOC; SI#54 DOC
DOEF
PiHKAL#65 DOEF
DOET
PiHKAL#66 DOET; SI#56 DOET
DOI
PiHKAL#67 DOI; SI#58 DOI
DOM
PiHKAL#68 DOM; SI#60 DOM
DON
PiHKAL#70 DON; SI#61 DON
DOPR
PiHKAL#71 DOPR; SI#62 DOPR
MPM
PiHKAL#138 MPM
TMA-2
PiHKAL#158 TMA-2; SI#118 TMA-2
DOF
DOF; 2,5-Dimethoxy-4-fluoro-amphetamine
DOIB
DOIB; 2,5-Dimethoxy-4-(2-methylpropyl)amphetamine
DOTB
DOTB; 2,5-Dimethoxy-4-(1,1-dimethylethyl)amphetamine
DOSB
DOSB; 2,5-Dimethoxy-4-(1-methylpropyl)amphetamine
DONH · DOA
DONH; 2,5-Dimethoxy-4-aminoamphetamine
DOAA
DOAA; 2,5-Dimethoxy-4-acetamidoamphetamine
Hydroxy-DOPR
Hydroxy-DOPR; 2,5-Dimethoxy-4-(1-hydroxypropyl)amphetamine
DOIP
DOIP; 2,5-Dimethoxy-4-isopropylamphetamine
MIPM
MIPM; 2,5-Dimethoxy-4-isopropoxyamphetamine
MBM
MBM; 4-n-Butoxy-2,5-dimethoxyamphetamine
MAM
MAM; 4-n-Amyloxy-2,5-dimethoxyamphetamine
DOHE
DOHE; 4-Hexyl-2,5-dimethoxyamphetamine
DOBZ
DOBZ; 4-Benzyl-2,5-dimethoxyamphetamine
DOCPM
DOCPM; 4-Cyclopropylmethyl-2,5-dimethoxyamphetamine
ALEPH-8
ALEPH-8; 4-Cyclopropylmethylthio-2,5-dimethoxyamphetamine
ALEPH-5
ALEPH-5; 4-Cyclohexylthio-2,5-dimethoxyamphetamine
ALEPH-16
ALEPH-16; 4-Allylthio-2,5-dimethoxyamphetamine
ALEPH-21
ALEPH-21; 4-(2-Fluoroethylthio)-2,5-dimethoxyamphetamine
DOTFM
DOTFM; 2,5-Dimethoxy-4-(trifluoromethyl)amphetamine
2328
2,5-Dimethoxy-4-phenylbutylamphetamine
DOYN
DOYN; 4-Ethynyl-2,5-dimethoxyamphetamine
DOCN
DOCN; 4-Cyano-2,5-dimethoxyamphetamine
DOPh3
DOPh3; 2,5-Dimethoxy-4-phenylpropylamphetamine
2325
2,5-Dimethoxy-4-phenethylamphetamine
2329
4-(4-Chlorophenylpropyl)-2,5-dimethoxyamphetamine
2330
2,5-Dimethoxy-4-(4-methoxyphenylpropyl)amphetamine
DOVI
DOVI; 1-(4-Ethenyl-2,5-dimethoxyphenyl)propan-2-amine
DOAC
DOAC; 4-Acetyl-2,5-dimethoxyamphetamine
DOCA
DOCA; 4-Carboxy-2,5-dimethoxyamphetamine
DOOH
DOOH; 4-Hydroxy-2,5-dimethoxyamphetamine
DOCONHP
DOCONHP; 2,5-Dimethoxy-4-(propylaminocarbonyl)amphetamine
DOCOE
DOCOE; 2,5-Dimethoxy-4-propanonylamphetamine
DOCEB
DOCEB; 4-Butoxycarbonyl-2,5-dimethoxyamphetamine
DOCEP
DOCEP; 2,5-Dimethoxy-4-propoxycarbonylamphetamine
DOOC
DOOC; 2,5-Dimethoxy-4-n-octylamphetamine
DONMM
DONMM; 4-(2-Aminopropyl)-2,5-dimethoxy-N,N-dimethylaniline
DOFM
DOFM; 1-[4-(Fluoromethyl)-2,5-dimethoxyphenyl]propan-2-amine
DOHM
DOHM; 4-(2-Aminopropyl)-2,5-dimethoxybenzaldehyde
DOHP
DOHP; 1-(4-Heptyl-2,5-dimethoxyphenyl)propan-2-amine
DONO
DONO; 1-(2,5-Dimethoxy-4-nonylphenyl)propan-2-amine
DOEH
DOEH; 2-[4-(2-Aminopropyl)-2,5-dimethoxyphenyl]ethanol
M(2OP)M
M(2OP)M; 1-[4-(2-Aminopropyl)-2,5-dimethoxyphenoxy]propan-2-ol
M(3OP)M
M(3OP)M; 3-[4-(2-Aminopropyl)-2,5-dimethoxyphenoxy]propan-1-ol
MBZM
MBZM; 1-[4-(Benzyloxy)-2,5-dimethoxyphenyl]propan-2-amine
ALEPH-19
ALEPH-19; 1-[4-(Butylsulfanyl)-2,5-dimethoxyphenyl]propan-2-amine
ALEPH-S-amyl
ALEPH-S-amyl; 1-[2,5-Dimethoxy-4-(pentylsulfanyl)phenyl]propan-2-amine
ALEPH-S-PhEt
ALEPH-S-PhEt; 1-{2,5-Dimethoxy-4-[(2-phenylethyl)sulfanyl]phenyl}propan-2-amine
ALEPH sulfone